Atria Investments, Inc

Position in NBIX — Neurocrine Biosciences Inc

CIK 1535865 Charlotte, NC

Position in NBIX

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$1,441,103

-$47,544 QoQ

Shares Held

10,939

+4.2% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

9 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Atria Investments, Inc holds $19,449,833 across 15 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (7.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	62,275	$7,361,527
2	ELAN	Elanco Animal Health Inc	102,225	$2,446,244
3	VTRS	Viatris Inc	146,223	$1,975,472
4	HLN	Haleon plc	166,608	$1,667,746
5	NBIX	Neurocrine Biosciences Inc This page	10,939	$1,441,103
6	TEVA	Teva Pharmaceutical Industries Ltd	32,952	$992,514
7	PBH	Prestige Consumer Healthcare Inc.	14,395	$853,191
8	UTHR	UNITED THERAPEUTICS Corp	1,132	$671,253

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,441,103	10,939	+4.2%	Shares	Sole	2026-05-05
2025-12-31	$1,488,647	10,496	-3.3%	Shares	Sole	2026-02-05
2025-09-30	$1,523,123	10,850	+1.6%	Shares	Sole	2025-11-06
2025-06-30	$1,341,615	10,674	+15.3%	Shares	Sole	2025-08-04
2025-03-31	$1,024,045	9,259	+81.7%	Shares	Sole	2025-05-06
2024-12-31	$695,467	5,095	-7.3%	Shares	Sole	2025-02-06
2024-09-30	$633,133	5,495	-19.2%	Shares	Sole	2024-11-01
2024-06-30	$936,431	6,802	-36.5%	Shares	Sole	2024-08-13
2021-03-31	$1,041,547	10,710	—	Shares	Sole	2021-05-11
No filing history on record for this holder in this stock.